| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 730-735, Copyright © 1994 by Endocrine Society
ARTICLES |
A Blumsohn, K Herrington, RA Hannon, P Shao, DR Eyre and R Eastell
Department of Human Metabolism and Clinical Biochemistry, University of Sheffield, England.
Bone resorption shows a circadian rhythm in human subjects, but the physiological mechanisms underlying this rhythm are unknown. We compared the circadian rhythm of bone collagen degradation in 18 premenopausal women before and after oral calcium supplementation (1000 mg calcium for 14 days). Subjects were randomized to receive calcium at either 0800 h or 2300 h. Continuous 48-h urine collections and 1 day of 4-h urine collections were obtained before and after the 14-day supplementation period. We measured urinary deoxypyridinoline (Dpd) and the cross-linked N-telopeptide of type I collagen (NTx) as biochemical markers of bone resorption. There was a significant effect of time of day on excretion of Dpd and NTx (analysis of variance, P < 0.001) with peak excretion between 0300-0700 h and a nadir between 1500-1900 h. The mean amplitude (peak to trough) was similar for Dpd and NTx (70.3% and 63.3%, respectively). Evening calcium supplementation resulted in marked suppression of the nocturnal increase in Dpd and NTx and reversed the usual nocturnal increase in the level of parathyroid hormone. In contrast, morning calcium supplementation had no significant effect on the circadian rhythm of Dpd or NTx. Evening calcium supplementation suppressed overall daily excretion of Dpd by 20.1% (P = 0.03) and NTx by 18.1% (P = 0.03). Morning calcium supplementation had no significant effect on overall daily excretion of either Dpd or NTx. We conclude that evening calcium supplementation suppresses the circadian rhythm of bone resorption. The daily rhythm of PTH secretion or calcium intake is likely to be an important determinant of this rhythm. Experimental protocols designed to investigate the effect of calcium supplementation on bone mineral density should take the timing of supplementation into account.
This article has been cited by other articles:
![]() |
H. L Lambert, R. Eastell, K. Karnik, J. M Russell, and M. E Barker Calcium supplementation and bone mineral accretion in adolescent girls: an 18-mo randomized controlled trial with 2-y follow-up Am. J. Clinical Nutrition, February 1, 2008; 87(2): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Jackson, A. Blumsohn, A. E. Goodship, A. M. Wilson, and J. S. Price Circadian variation in biochemical markers of bone cell activity and insulin-like growth factor-I in two-year-old horses J Anim Sci, November 1, 2003; 81(11): 2804 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Clowes, H. C. Allen, D. M. Prentis, R. Eastell, and A. Blumsohn Octreotide Abolishes the Acute Decrease in Bone Turnover in Response to Oral Glucose J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4867 - 4873. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-H. Lin, F. Ginty, L. J. Appel, M. Aickin, A. Bohannon, P. Garnero, D. Barclay, and L. P. Svetkey The DASH Diet and Sodium Reduction Improve Markers of Bone Turnover and Calcium Metabolism in Adults J. Nutr., October 1, 2003; 133(10): 3130 - 3136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maurer, W. Riesen, J. Muser, H. N. Hulter, and R. Krapf Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans Am J Physiol Renal Physiol, January 1, 2003; 284(1): F32 - F40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Clowes, R. T. Robinson, S. R. Heller, R. Eastell, and A. Blumsohn Acute Changes of Bone Turnover and PTH Induced by Insulin and Glucose: Euglycemic and Hypoglycemic Hyperinsulinemic Clamp Studies J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3324 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline Clin. Chem., February 1, 2002; 48(2): 220 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. U. Karkkainen, C. J. Lamberg-Allardt, S. Ahonen, and M. Valimaki Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism Am. J. Clinical Nutrition, September 1, 2001; 74(3): 335 - 342. [Abstract] [Full Text] |
||||
![]() |
O. D. Wolthers, C. Heuck, and L. Heickendorff Diurnal Variations in Serum and Urine Markers of Type I and Type III Collagen Turnover in Children Clin. Chem., September 1, 2001; 47(9): 1721 - 1722. [Full Text] [PDF] |
||||
![]() |
M. E. Wastney, B. R. Martin, M. Peacock, D. Smith, X.-Y. Jiang, L. A. Jackman, and C. M. Weaver Changes in Calcium Kinetics in Adolescent Girls Induced by High Calcium Intake J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4470 - 4475. [Abstract] [Full Text] |
||||
![]() |
A. Zittermann, I. Schwarz, K. Scheld, T. Sudhop, H. K. Berthold, K. von Bergmann, H. van der Ven, and P. Stehle Physiologic Fluctuations of Serum Estradiol Levels Influence Biochemical Markers of Bone Resorption in Young Women J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 95 - 101. [Abstract] [Full Text] |
||||
![]() |
M. Sarno, H. Powell, G. Tjersland, D. Schoendorfer, H. Harris, K. Adams, P. Ogata, and G. R. Warnick A Collection Method and High-Sensitivity Enzyme Immunoassay for Sweat Pyridinoline and Deoxypyridinoline Cross-Links Clin. Chem., September 1, 1999; 45(9): 1501 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Watts Clinical Utility of Biochemical Markers of Bone Remodeling Clin. Chem., August 1, 1999; 45(8): 1359 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Hotchkiss and C. P. Jerome Evaluation of a nonhuman primate model to study circadian rhythms of calcium metabolism Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R494 - R501. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Eastell Treatment of Postmenopausal Osteoporosis N. Engl. J. Med., March 12, 1998; 338(11): 736 - 746. [Full Text] [PDF] |
||||
![]() |
H.-S. J. Ju, S. Leung, B. Brown, M. A. Stringer, S. Leigh, C. Scherrer, K. Shepard, D. Jenkins, J. Knudsen, and R. Cannon Comparison of analytical performance and biological variability of three bone resorption assays Clin. Chem., September 1, 1997; 43(9): 1570 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sels, J. Dequeker, J. Verwilghen, and J-M. Mbuyi-Muamba SLE and osteoporosis: dependence and/or independence on glucocorticoids Lupus, April 1, 1996; 5(2): 89 - 92. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |